COVID-19 update: At this time there are no interruptions in our ability to manufacture and supply product. Our clinical team has instituted virtual video trainings for new pump and CGM customers to ensure continuity of service. Please click here for more information. X

innovation Archive

Medtronic Announces FDA Approval for MiniMed 770G Insulin Pump System

For people on the MiniMed 770G system, the MiniMed Mobile app mirrors the pump screen to allow you to see your pump and continuous glucose monitoring (CGM) data on your personal phone.

Who Is Driving Innovation at Medtronic?

  At Medtronic, innovation is vital so that we can continue to improve the lives of people living with diabetes. Our Research & Development (R&D) team is at the center of that innovation. However, we realize that it’s important for the team to stay centered on patients’ needs. That’s why we focus on having

Important Update on MiniMed 670G Availability and the Priority Access Program

Last fall we announced the FDA approval of the world’s first hybrid closed loop system and it was one of the proudest days of my career. After 35 years of innovation, we’re thrilled to make this revolutionary technology a reality. The MiniMed 670G® system is the most advanced insulin pump and sensor system that

Breaking News: FDA Approves the MiniMed 670G System, World’s First Hybrid Closed Loop System

Today we have fantastic news to share – Medtronic has received FDA approval of the world’s first hybrid closed loop system! The MiniMed® 670G system is the most advanced insulin pump and sensor system designed to help people with type 1 diabetes spend less time worrying about their glucose  levels and more time living

Innovator Interview: The MiniMed 630G System

It’s an exciting time at Medtronic Diabetes! With the recent launch of the MiniMed® 630G system there are many people that have been working tirelessly to bring this product to life and into your hands. Here’s an insider perspective from Afshin Bazargan, Director of Research and Technology Development. Outside of work, Afshin has two